Sustained nuclear localization of p21/Waf-1 upon growth arrest induced by contact inhibition

Cancer Letters

Volumn 158, Issue 1, 2000, Pages 73-84

  Ritt, Michelle G ^a   Mayor, Jocelyne ^b   Wojcieszyn, John ^b   Smith III, Roger ^b   Barton, Claudia L ^a   Modiano, Jaime F ^b  

^a TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Cell cycle; Contact inhibition; Cyclin dependent kinase inhibitor; Melanoma

Indexed keywords

CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR; NUCLEAR PROTEIN; PROTEIN P21; PROTEIN WAF 1; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTACT INHIBITION; CONTROLLED STUDY; DOG; ENZYME ACTIVITY; GENE OVEREXPRESSION; GROWTH CURVE; MELANOMA; MELANOMA CELL; MITOSIS; MITOSIS INHIBITION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ANIMALS; APOPTOSIS; CELL CYCLE; CELL DIVISION; CELL NUCLEUS; CONTACT INHIBITION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DOGS; IMMUNOBLOTTING; MELANOMA; SUBCELLULAR FRACTIONS; TUMOR CELLS, CULTURED;

EID: 0034730945     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(00)00507-3     Document Type: Article

References (39)

1. El-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., Lin D., Mercer W.E., Kinzler K.W., Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell. 75:1993;817-825.
2. El-Deiry W.S., Tokino T., Waldman T., Oliner J.D., Velculescu V.E., Burrell M., Hill D.E., Healy E., Rees J.L., Hamilton S.R., Kinzler K.W., Vogelstein B. Topological control of p21/waf1/cip1 expression in normal and neoplastic tissues. Cancer Res. 55:1995;2910-2919.
3. Miele M.E., Robertson G., Lee J.H., Coleman A., McGary C.T., Fisher P.B., Lugo T.G., Welch D.R. Metastasis suppressed, but tumorigenicity and local invasiveness unaffected, in the human melanoma cell line MelJuSo after introduction of human chromosomes 1 or 6. Mol. Carcinog. 15:1996;284-299.
4. Jiang H., Lin J., Su Z.Z., Herlyn M., Kerbel R.S., Weissman B.E., Welch D.R., Fisher P.B. The melanoma differentiation-associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells. Oncogene. 10:1995;1855-1864.
5. Gartel A.L., Serfas M.S., Tyner A.L. p21 - negative regulator of the cell cycle. Proc. Soc. Exp. Biol. Med. 213:1996;138-149.
6. Missero C., Di Cunto F., Kiyokawa H., Koff A., Dotto G.P. The absence of p21Cip1/WAF1 alters keratinocyte growth and differentiation and promotes ras-tumor progression. Genes Dev. 10:1996;3065-3075.
7. LaBaer J., Garrett M.D., Stevenson L.F., Slingerland J.M., Sandhu C., Chou H.S., Fattaey A., Harlow E. New functional activities for the p21 family of CDK inhibitors. Genes Dev. 11:1997;847-862.
8. Xiong Y., Hannon G.J., Zhang H., Casso D., Kobayashi R., Beach D. p21 is a universal inhibitor of cyclin kinases. Nature. 366:1993;701-704.
9. Harper J.W., Adami G.R., Wei N., Keyomarsi K., Elledge S.J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 75:1993;805-816.
10. Harper J.W., Elledge S.J., Keyomarsi K., Dynlacht B., Tsai L.H., Zhang P., Dobrowolski S., Bai C., Connell-Crowley L., Swindell E., Fox M.P., Wei N. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell. 6:1995;387-400.
11. Barboule N., Chadebech P., Baldin V., Vidal S., Valette A. Involvement of p21 in mitotic exit after paclitaxel treatment in MCF-7 breast adenocarcinoma cell line. Oncogene. 15:1997;2867-2875.
12. Shim J., Lee H., Park J., Kim H., Choi E.J. A non-enzymatic p21 protein inhibitor of stress-activated protein kinases. Nature. 381:1996;804-806.
13. Chen J., Jackson P.K., Kirschner M.W., Dutta A. Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA. Nature. 374:1995;386-388.
14. Waga S., Hannon G.J., Beach D., Stillman B. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature. 369:1994;574-578.
15. Li R., Hannon G.J., Beach D., Stillman B. Subcellular distribution of p21 and PCNA in normal and repair-deficient cells following DNA damage. Curr. Biol. 6:1996;189-199.
16. Li Y., Jenkins C.W., Nichols M.A., Xiong Y. Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21. Oncogene. 9:1994;2261-2268.
17. Macleod K.F., Sherry N., Hannon G., Beach D., Tokino T., Kinzler K., Vogelstein B., Jacks T. p53-Dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev. 9:1995;935-944.
18. Zhang W., Grasso L., McClain C.D., Gambel A.M., Cha Y., Travali S., Deisseroth A.B., Mercer W.E. p53-Independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation. Cancer Res. 55:1995;668-674.
19. Guo K., Wang J., Andres V., Smith R.C., Walsh K. MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation. Mol. Cell Biol. 15:1995;3823-3829.
20. Evers B.M., Ko T.C., Li J., Thompson E.A. Cell cycle protein suppression and p21 induction in differentiating Caco-2 cells. Am. J. Physiol. 271:1996;G722-G727.
21. El-Deiry W.S., Tokino T., Waldman T., Oliner J.D., Velculescu V.E., Burrell M., Hill D.E., Healy E., Rees J.L., Hamilton S.R., Kinzler K.W., Vogelstein B. Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res. 55:1995;2910-2919.
22. Datto M.B., Li Y., Panus J.F., Howe D.J., Xiong Y., Wang X.F. Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc. Natl. Acad. Sci. USA. 92:1995;5545-5549.
23. Elbendary A., Berchuck A., Davis P., Havrilesky L., Bast R.C. Jr., Iglehart J.D., Marks J.R. Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells. Cell Growth Differ. 5:1994;1301-1307.
24. Parker S.B., Eichele G., Zhang P., Rawls A., Sands A.T., Bradley A., Olson E.N., Harper J.W., Elledge S.J. p53-Independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science. 267:1995;1024-1027.
25. Mazars P., Barboule N., Baldin V., Vidal S., Ducommun B., Valette A. Effects of TGF-beta 1 (transforming growth factor-beta 1) on the cell cycle regulation of human breast adenocarcinoma (MCF-7) cells. FEBS Lett. 362:1995;295-300.
26. Modiano J.F., Ritt M.G., Wojcieszyn J., Smith R. III. Growth arrest of melanoma cells is differentially regulated by contact inhibition and serum deprivation. DNA Cell Biol. 18:1999;357-367.
27. Ritt M.G., Wojcieszyn J., Modiano J.F. Functional loss of p21/Waf-1 in a case of benign canine multicentric melanoma. Vet. Pathol. 35:1998;94-101.
28. Modiano J.F., Amran D.A., Lack G., Bradley K., Ball C., Domenico J., Gelfand E.W. Post-transcriptional regulation of T cell IL-2 production by human pooled immunoglobulin. Clin. Immunol. Immunopathol. 83:1997;77-85.
29. Modiano J.F., Kokai Y., Weiner D.B., Pykett M.J., Nowell P.C., Lyttle C.R. Progesterone augments proliferation induced by epidermal growth factor in a feline mammary adenocarcinoma cell line. J. Cell. Biochem. 45:1991;196-206.
30. Modiano J.F., Domenico J., Szepesi A., Lucas J.J., Gelfand E.W. Differential requirements for interleukin-2 distinguish the expression and activity of the cyclin-dependent kinases Cdk4 and Cdk2 in human T cells. J. Biol. Chem. 269:1994;32972-32978.
31. Morgan D.O. Principles of CDK regulation. Nature. 374:1995;131-134.
32. Chiarugi V., Magnelli L., Cinelli M., Basi G. Apoptosis and the cell cycle. Cell. Mol. Biol. Res. 40:1994;603-612.
33. Helfand S.C., Dickerson E.B., Munson K.L., Padilla M.L. GD3 ganglioside antibody augments tumoricidal capacity of canine blood mononuclear cells by induction of interleukin 12. Cancer Res. 59:1999;3119-3127.
34. Barboule N., Baldin V., S J.O., Vidal S., Valette A. Increased level of p21 in human ovarian tumors is associated with increased expression of cdk2, cyclin A and PCNA. Int. J. Cancer. 76:1998;891-896.
35. Jiang H., Lin J., Su Z.Z., Collart F.R., Huberman E., Fisher P.B. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene. 9:1994;3397-3406.
36. St.Croix B., Sheehan C., Rak J.W., Florenes V.A., Slingerland J.M., Kerbel R.S. E-Cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27(Kip1). J. Cell Biol. 142:1998;557-571.
37. Kato A., Takahashi H., Takahashi Y., Matsushime H. Inactivation of the cyclin D-dependent kinase in the rat fibroblast cell line, 3y1, induced by contact inhibition. J. Biol. Chem. 272:1997;8065-8070.
38. Brugarolas J., Bronson R.T., Jacks T. p21 is a critical CDK2 regulator essential for proliferation control in Rb-deficient cells. J. Cell Biol. 141:1998;503-514.
39. Boudreau N., Werb Z., Bissell M.J. Suppression of apoptosis by basement membrane requires three-dimensional tissue organization and withdrawal from the cell cycle. Proc. Natl. Acad. Sci. USA. 93:1996;3509-3513.